New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
about
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?Adiponectin signaling and function in insulin target tissuesKinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in HumansCysteine and hydrogen sulphide in the regulation of metabolism: insights from genetics and pharmacologyWhy Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes.The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes.Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.Insulin Resistance in Relation to Lipids and Inflammation in Type-2 Diabetic Patients and Non-Diabetic PeopleEffect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placeboHepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study.Neuronal human BACE1 knockin induces systemic diabetes in mice.The impact of preconceptional obesity on trajectories of maternal lipids during gestation.Salvia officinalis (Sage) Leaf Extract as Add-on to Statin Therapy in Hypercholesterolemic Type 2 Diabetic Patients: a Randomized Clinical Trial.Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.Identification of Shared and Unique Serum Lipid Profiles in Diabetes Mellitus and Myocardial InfarctionNMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls.HDL cholesterol: reappraisal of its clinical relevance.Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis.The Q192R polymorphism of the paraoxonase-1 (PON1) gene is associated with susceptibility to gestational diabetes mellitus in the Greek population.Modulation of the vascular endothelium functioning by dietary components, the role of epigenetics.Systems Biology to Support Nanomaterial Grouping.TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.Dyslipidaemia and its treatment in patients with type 2 diabetes - a joint analysis of the German DIVE and DPV registries.Centella asiatica enhances hepatic antioxidant status and regulates hepatic inflammatory cytokines in type 2 diabetic rats.Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study.Glycation of high-density lipoprotein triggers oxidative stress and promotes the proliferation and migration of vascular smooth muscle cells.Results of the Adequacy of glycemiC Control in pAtients with type 2 Diabetes mEllitus treated with Metformin monotherapY at the maximal-tolerated dose (ACCADEMY) study.Association of trace metal elements with lipid profiles in type 2 diabetes mellitus patients: a cross sectional study.Transition from pre-diabetes to diabetes and predictors of risk in Mexican-Americans.Suppression of Hepatic FLOT1 (Flotillin-1) by Type 2 Diabetes Mellitus Impairs the Disposal of Remnant Lipoproteins via Syndecan-1.Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.Evidence for increased chylomicron remnants in rheumatoid arthritis.Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials.[Clinical importance of HDL cholesterol].Unexplained reciprocal regulation of diabetes and lipoproteins.PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders.Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study.Plant sterols lower LDL-cholesterol and triglycerides in dyslipidemic individuals with or at risk of developing type 2 diabetes; a randomized, double-blind, placebo-controlled study.
P2860
Q26746279-6054136C-8B3F-4857-9CA7-F3C5714E1EC5Q26753354-72DAF736-A3BD-4F6F-9E80-8C17F4040140Q26774776-2200D93B-51FC-4A43-9EA6-D974EF07E0B0Q26782965-9389F654-CCF7-480A-AB03-4A1550877DBCQ28077776-DD853FDE-5FED-48F9-8F53-3924C9D2CCF4Q30234825-FDC6A1C6-DB5C-4CA0-99EA-9A07C32112B4Q33771752-F0D32E99-595F-45EC-B00F-1D3D8559FD54Q33918771-462E94D1-0FED-480B-B64B-EDFB53811F51Q35928257-2C33039C-AD78-43B3-BC6E-496D46CBC2DAQ35988339-8BB124C5-7661-451C-8BC7-C14EB3E3083BQ36577724-A81725CB-2FDF-43A7-B7F9-695FA2C8D0D9Q36815362-CFAE1FBF-0744-456C-9A14-2BFB7964FF58Q36990153-88AD4BC1-70C6-4F95-AF4F-2A2A7892C6A1Q37110882-3807FEFC-18BE-45FF-A7C9-51F1803ADF3EQ37445462-3193119D-897E-4ABA-80BF-C5D9F46415D9Q37474214-E8777200-B48D-46E4-BBD7-7A292E12AC1DQ37556343-12444247-C0CC-48EE-9CEB-87D9E9AE64E2Q38652409-FB526F99-BF24-4999-A4E3-963EA3EF28FEQ38739884-3F66D4DD-AF5A-4F0C-83AD-2089E56C70EEQ38763036-ABC2BE27-2CF6-4DEA-8522-1E7420DD3EF4Q38873483-9B798A3C-65DB-489D-A8CA-699A44FC9EBEQ38880608-8D42D479-6E60-400C-9905-47AD245E42AEQ38974885-FE50C161-40DB-43CB-8EF5-32D687AB5728Q39062036-BABE4AAA-7ED6-43EB-ADC3-28E7C7951896Q39424127-3E707288-DE46-45C7-BDB9-3F6909EE888EQ40464316-9F4DB746-B868-4CE8-9C70-81B86FFFE47CQ41145464-37309796-866A-4AAB-8068-1CBB60A84510Q41265501-E01F0EBB-8CFF-415E-B9FF-B2A02EED8E11Q41481445-CAF817EC-B4B7-4033-AFF4-5E76BD07F4DFQ42377426-C5FF32FB-9199-4811-AF43-CDA546D0698EQ47124822-F32E57F4-D5E8-4C43-BC03-09AA9F148EF6Q47377600-C585D308-5B30-485E-A0B4-781779406AFAQ47557757-3EE7BC56-9665-4932-88DD-F2453AA6A513Q48134335-49D6474F-D721-4E75-93F2-0AD3CAB681A0Q51597934-8BF1F6E9-E310-4DC1-B750-44951AD11F4BQ52813315-32787506-2AF0-4125-9E69-A4F4600C2EA3Q53690107-05697C80-61A9-4535-B5A1-348C4ABC8BCEQ53825590-AD230173-5D33-48A2-92E1-28482FB4CEA9Q54996163-1EB160ED-2A52-45B1-9610-A8F3471CF824Q55109032-E9B563CB-A52E-4E07-8D63-B42E0B469395
P2860
New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
@en
type
label
New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
@en
prefLabel
New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
@en
P921
P1433
P1476
New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
@en
P2093
Marja-Riitta Taskinen
P304
P356
10.1016/J.ATHEROSCLEROSIS.2015.01.039
P50
P577
2015-02-07T00:00:00Z